BiomX Q2 EPS $(0.07) Up From $(0.12) YoY; Cash Balance, Short-term Deposits And Restricted Cash As Of June 30, 2024, Were $32.7M, Sufficient To Fund Its Operations Through The Fourth Quarter Of 2025
BiomX Q2 EPS $(0.07) Up From $(0.12) YoY; Cash Balance, Short-term Deposits And Restricted Cash As Of June 30, 2024, Were $32.7M, Sufficient To Fund Its Operations Through The Fourth Quarter Of 2025
BiomX二季度每股收益爲$(0.07)，同比$(0.12)上升；截至2024年6月30日的現金餘額、短期存款和受限現金爲3270萬美元，足以支持其經營活動至2025年第四季度。
BiomX Q2 EPS $(0.07) Up From $(0.12) YoY; Cash Balance, Short-term Deposits And Restricted Cash As Of June 30, 2024, Were $32.7M, Sufficient To Fund Its Operations Through The Fourth Quarter Of 2025
BiomX二季度每股收益爲$(0.07)，同比$(0.12)上升；截至2024年6月30日的現金餘額、短期存款和受限現金爲3270萬美元，足以支持其經營活動至2025年第四季度。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間